Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Cabaletta Bio, Inc. CABA | Redmile Group, LLC | 696,377 2.500% | -681,942 (-49.48%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | AVITA Medical, Inc. RCEL | Redmile Group, LLC | 672,411 2.700% | -1,034,975 (-60.62%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | Redmile Group, LLC | 277,214 9.900% | 11,823 (+4.46%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group, LLC | 664,817 1.100% | -3,773,151 (-85.02%) | Filing History |
| 2022-01-14 5:16 pm Unchanged | 2022-01-10 | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group, LLC | 227,601 34.300% | 0 (Unchanged) | Filing History |
| 2021-11-29 5:01 pm Sale | 2021-11-29 | 13D | MedAvail Holdings, Inc. MDVL | Redmile Group, LLC | 227,601 34.300% | -12,992 (-5.40%) | Filing History |
| 2021-11-01 4:05 pm Purchase | 2021-10-28 | 13D | Augmedix, Inc. AUGX | Redmile Group, LLC | 15,871,125 41.100% | 1,625,000 (+11.41%) | Filing History |
| 2021-10-18 4:05 pm Purchase | 2021-10-06 | 13D | Science 37 Holdings, Inc. SNCE | Redmile Group, LLC | 990,412 17.300% | 990,412 (New Position) | Filing History |
| 2021-09-27 4:01 pm Purchase | 2021-09-17 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group, LLC | 5,729,916 9.900% | 814,187 (+16.56%) | Filing History |
| 2021-08-02 5:00 pm Purchase | 2021-07-21 | 13D | Absci Corporation ABSI | Redmile Group, LLC | 8,031,094 8.700% | 8,031,094 (New Position) | Filing History |
| 2021-06-07 4:09 pm Purchase | 2021-05-28 | 13G | Dynamics Special Purpose Corp. DYNS | Redmile Group, LLC | 2,012,900 8.500% | 2,012,900 (New Position) | Filing History |
| 2021-04-08 4:11 pm Purchase | 2021-03-29 | 13G | LAVA Therapeutics N.V. LVTX | Redmile Group, LLC | 2,824,409 11.100% | 2,824,409 (New Position) | Filing History |
| 2021-03-02 4:10 pm Purchase | 2021-02-23 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Redmile Group, LLC | 1,381,077 9.990% | 713,261 (+106.81%) | Filing History |
| 2021-03-01 06:05 am Unchanged | 2021-02-22 | 13D | Augmedix, Inc. AUGX | Redmile Group, LLC | 14,246,125 50.400% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:27 pm Purchase | 2020-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,647,696 7.200% | 2,647,696 (New Position) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Itamar Medical Ltd. ITMR | Redmile Group, LLC | 21,345,000 5.000% | 21,345,000 (New Position) | Filing History |
| 2021-02-16 4:11 pm Sale | 2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Redmile Group, LLC | 2,397,441 4.900% | -603,200 (-20.10%) | Filing History |
| 2021-02-16 4:11 pm Sale | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | Redmile Group, LLC | 0 0.000% | -3,430,529 (Position Closed) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group, LLC | 4,658,043 9.900% | 1,036,408 (+28.62%) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 2,846,125 7.300% | 2,846,125 (New Position) | Filing History |